SELNECITY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SELNECITY Trademark

Serial Number: 79398416 • Registration: 8131528

SELNECITY is a trademark filed by Boehringer Ingelheim International GmbH on May 6, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim International GmbH (4 trademarks)

Binger Strasse 173
Ingelheim 55218 , DE

Entity Type: 03

Trademark Details

Filing Date

May 6, 2024

Registration Date

February 10, 2026

Published for Opposition

December 17, 2024

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases; excluding pharmaceutical preparations to treat hormonal diseases and disorders, endocrine diseases and disorders and congenital adrenal hyperplasia

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 22, 2026 LIMN
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jan 15, 2026 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 15, 2026 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 15, 2026 OP.D
LIMITATION OF GOODS RECEIVED FROM IB
Jan 1, 2026 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
LIMITATION OF GOODS RECEIVED FROM IB
Oct 24, 2025 LIMG
REFUSAL PROCESSED BY IB
Jul 5, 2025 RFNP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 18, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Jun 18, 2025 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Jun 16, 2025 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jun 15, 2025 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 16, 2025 ETOF
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTICE OF PUBLICATION
Dec 11, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2024 CNSA
ASSIGNED TO EXAMINER
Nov 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 23, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2024 REPR